Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 3,192 | 1,401 | 3,073 | 1,353 | 2,672 |
| Gross Profit | 3,192 | 1,401 | 3,073 | 1,353 | 2,672 |
| Operating Expenses | 57,173 | 55,786 | 53,667 | 68,718 | 187,103 |
| Operating Income | -53,981 | -54,385 | -50,594 | -67,365 | -184,431 |
| Other Income | -11,946 | -11,164 | -16,990 | -3,814 | -2,563 |
| Pre-tax Income | -65,927 | -65,549 | -67,584 | -71,179 | -186,994 |
| Income Tax | -151 | -93 | -3 | -22,240 | -52 |
| Net Income Continuous | -65,776 | -65,456 | -67,581 | -48,939 | -186,942 |
| Net Income | $-65,776 | $-65,456 | $-67,581 | $-48,939 | $-186,942 |
| EPS Basic Total Ops | -1.91 | -1.94 | -2.03 | -1.47 | -6.10 |
| EPS Basic Continuous Ops | -1.90 | -1.94 | -2.03 | -1.47 | -6.10 |
| EPS Diluted Total Ops | -1.91 | -1.94 | -2.03 | -1.47 | -6.10 |
| EPS Diluted Continuous Ops | -1.90 | -1.94 | -2.03 | -1.47 | -6.10 |
| EBITDA(a) | $-52,001 | $-52,409 | $-46,636 | $-66,598 | $-183,801 |